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Mining the Virome for Insights into Type 1 Diabetes
Arnold Park and Guoyan Zhao
Type 1 diabetes (T1D) is characterized by the autoimmune destruction of insulin-producing pancreatic beta cells.
Although environmental factors interplay with genetic susceptibility to promote immune dysregulation and disease,
it remains unclear as to which potential environmental factors are causative and not simply correlative. Despite
many hints that the microbiome can have a profound effect on T1D, significant changes in bacterial gut flora and
diversity appear to emerge only after the detection of early signs of T1D. Surprisingly, we recently found significant
differences in the gut virome preceding the initial signs of T1D, raising the tantalizing possibility that the state of
the virome may influence or predict whether susceptible individuals progress on the path to disease. The challenge
will be to discern whether there is likely a causative relationship between detected virome differences and T1D.
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Viruses in Type 1 Diabetes: Friend or Foe?
T ype 1 diabet es (T1D) usua l l y r ear s its head at ayoung age, although T1D can develop later on in life as
well (Diaz-Valencia et al., 2015). Initially, the appearance of
autoantibodies that are specific for the pancreatic islets, or
‘‘seroconversion,’’ serves as a non-pathogenic biomarker of
preclinical disease development. As autoimmunity progresses,
patients develop T cell-mediated autoimmune destruction of
the pancreatic beta cells, resulting in loss of insulin production
and, thus, dysglycemia (Coppieters et al., 2012b; Katsarou
et al., 2017). Many genetic factors confer susceptibility to
T1D, particularly certain variants of the highly diverse human
leukocyte antigen (HLA) locus important for antigen presen-
tation (Pociot and Lernmark, 2016). However, identical twins
often do not share the same T1D outcome, indicating that the
environment plays a critical role in triggering disease (Re-
dondo et al., 2008). Many candidate environmental factors,
including diet, hygiene, psychological stress, commensal mi-
crobiota, and viral infections, have been examined for their
potential effects on T1D (Rewers and Ludvigsson, 2016).
In animal models, viruses can either trigger or prevent T1D,
each via various potential mechanisms (Ghazarian et al.,
2013). Although a number of viruses have been proposed as
suspect triggers of T1D in people, most lack convincing con-
firmation or continued major relevance (Coppieters et al.,
2012a). For example, despite reports implicating Mumps in-
fection, clearly the near eradication of Mumps in many coun-
tries has not stemmed the continued rise of T1D (Honeyman,
2005). However, a growing body of evidence indicates that
enteroviruses (family Picornaviridae, genus Enterovirus) may
have a triggering role in T1D (Oikarinen et al., 2011; Yeung
et al., 2011; Krogvold et al., 2015). The apparent inverse re-
lationship between geographic exposure to enterovirus and
T1D incidence would seem to argue against a causative rela-
tionship (Viskari et al., 2004, 2005); however, as Viskari et al.
and others have speculated, it is possible that a lower preva-
lence of enterovirus in the population would lead to reduced
pre-existing immunity and altered timing of infection, perhaps
resulting in a disease course that is more likely to lead to T1D
(Tracy et al., 2010). Notably, in the non-obese diabetic (NOD)
mouse model of spontaneous T1D, enterovirus infection can
prevent diabetes if administered early (Tracy et al., 2002; Fi-
lippi et al., 2009), but it accelerates diabetes if administered
later in the course of disease development (Serreze et al.,
2000). Whether enteroviruses are, indeed, causative agents of
T1D is a challenging question to conclusively address, perhaps
one that could only be truly settled by seeing the effect of
enterovirus eradication on T1D incidence.
Beyond enteroviruses and other specific candidate viru-
ses, it has not been explored whether unknown components
of our virome may play a role in T1D development. We
have but barely scratched the surface of the diversity and
biological import of the virome, which can have profound
impacts on host health (Virgin, 2014). Individual viral
species or groups of viruses may have unexpected roles in
promoting or ameliorating T1D.
The Gut Virome in T1D
Gut microbes and microbe-derived molecules interact
with the host to cause wide-ranging effects on systemic
immunity (Hooper et al., 2012). Further, the pancreas and
the gut have an intimate connection via the immune system,
with antigens from the gut being presented to immune cells in
the pancreatic lymph nodes (Turley et al., 2005). In contrast to
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the mainly candidate virus-based approach of previous work,
we took a broad and unbiased approach, shotgun metage-
nomics sequencing, to determine whether changes in the vir-
ome could be linked to development of T1D.
Before our examination of the virome, our colleagues
Kostic et al. examined the bacterial component of the gut
microbiome, because modulation of the intestinal bacterial
flora has a profound effect on T1D development in the NOD
mouse model (Knip and Siljander, 2016). To determine
whether predictive bacterial signatures could be discerned
for human T1D, Kostic et al. (2015) performed a longitu-
dinal case-control study in Finland and Estonia, neighboring
countries with differing standards of living. Finland has the
highest incidence of T1D in the world, whereas the preva-
lence of autoimmune disease is increasing rapidly in Estonia
as its standard of living rises. Monthly stool samples were
collected from genetically susceptible infants between the
ages of 1 month through 3 years, providing a densely col-
lected view into microbiome changes during the period of
life when the microbiome plays an important role in the
maturation and education of the immune system (Francino,
2014; Wang et al., 2016). In the end, the study encompassed
11 seroconverters (including 4 who further progressed to
diagnosed T1D during the study) along with controls mat-
ched for HLA risk allele genotype, age, sex, birth delivery
route, and country. For those children who progressed to
T1D, Kostic et al. (2015) noted a decrease in bacterial di-
versity between the detection of seroconversion and the
onset of T1D; however, no significant earlier bacterial sig-
natures were found that might predict seroconversion.
Seroconversion is a defining turning point in T1D de-
velopment that indicates risk of progression to clinical dis-
ease (Ziegler et al., 2013). We wondered whether examining
the virome in the Finland/Estonia cohort might reveal viral
signatures predictive of the early event of seroconversion.
All stool samples collected before seroconversion for the 11
seroconverters and corresponding matched controls were
processed and analyzed to favor detection of viral sequences
(Zhao et al., 2017). A highly diverse set of viruses was
detected, with sequence relationships to 178 defined viral
genera, including 33 genera of eukaryotic viruses. Of the
eukaryotic viruses, the only viral family to show a statistically
significant difference between eventual seroconverters and
control subjects was the Circoviridae, which contains non-
enveloped viruses with single-stranded, circular DNA ge-
nomes. These novel Circoviridae-related sequences classify
within the broader group of related circular Rep-encoding
ssDNA (CRESS DNA) viruses (Delwart and Li, 2012). We
were fascinated to find that CRESS DNA viruses were de-
tected only in control subjects (5 of 11) and not at all in the
seroconverters. Could it be that these viruses, which have thus
far been considered possible commensal viruses with no
known link to disease in humans (Virgin et al., 2009), actu-
ally play a protective role in T1D?
Viruses Can Be Beneficial to the Host
Each person harbors on average 8–12 chronic infections of
characterized viruses (Virgin et al., 2009), not to mention all
the viruses only glimpsed in deep sequencing of the virome.
Therefore, our bodies not only repel acute viral infections but
also coexist, perhaps at times in symbiosis, with persistent
viral infections. The interplay between these viruses and our
organismal cells and systems has a pervasive influence on
our development and health. Although dissecting this inter-
play is experimentally challenging, recent work has revealed
important insights. Kernbauer et al. (2014) showed that in-
troducing a persistent infection of murine norovirus resulted
in a type I IFN-dependent reversal of intestinal abnormalities
typically seen in germ-free mice, indicating that a virus can
supply signals that are important for host physiology. Other
work by Yang et al. (2016) suggests that toll-like receptor
(TLR)-mediated host recognition of enteric viruses maintains
intestinal homeostasis and resistance to intestinal injury.
Along similar lines, Sun et al. (2015) have shown that type I
IFN in response to persistent viral infection promotes epi-
thelial cell turnover and wound repair.
Could TLR-mediated type I IFN responses influence the
progression of T1D? In the NOD mouse model, TLR-mediated
immune signaling can repress or accelerate T1D, depending on
the specific TLR and the experimental conditions used (Okada
et al., 2010; Tai et al., 2016). In genetically susceptible chil-
dren, a transient type I IFN transcriptional signature was noted
in the peripheral blood preceding seroconversion, suggesting
that type I IFN might actually promote disease (Ferreira et al.,
2014); arguing otherwise, however, is work showing that type
I IFN-deficient NOD mice are not less susceptible to T1D
compared with wild-type mice (Quah et al., 2014). Beyond
TLR-mediated responses, viruses might ameliorate T1D pro-
gression via a number of potential mechanisms: antigenic
competition between viral antigens and autoantigens, bystander
suppression of autoimmune responses on upregulation of reg-
ulatory immune cells in response to viral infection, and perhaps
diverse impacts on the immune system milieu that counter
specific T1D triggers (Virgin et al., 2009; Okada et al., 2010).
For example, if enteroviruses are truly triggers of T1D, could
infection with another component of the virome stimulate the
immune system in a manner that decreases the risk of en-
teroviruses reaching and infecting the pancreatic islets? Such a
virus-to-virus effect is quite possible, as it has been shown that
chronic herpesvirus infection can render the host resistant to
other infections (Barton et al., 2007).
The idea that components of the virome could provide
protection against T1D is consistent with the hygiene hy-
pothesis, which postulates that decreasing infections and en-
vironmental exposures in a given area is a driver of increased
autoimmunity (Okada et al., 2010). It is interesting that
CRESS DNA viruses (other than porcine circovirus, derived
from consuming pork products) were found in human stool
samples from Pakistan, Nigeria, and Tunisia but not the
United States (Li et al., 2010), indicating that the prevalence
of these viruses could be affected by standards of hygiene.
Bacteriophages May Point the Way
for Bacterial Changes in T1D
Bacteriophages represent the dominant viral component of
the gut virome (Ogilvie and Jones, 2015). Our analysis of
bacteriophage sequences in the Finland/Estonia cohort iden-
tified bacteriophage contigs that were predictive of age at the
time of sample collection, indicating that these bacteriophage
signatures were remarkably consistent across individuals and
might define the normal development of the virome. However,
the bacteriophage component of the virome, nevertheless,















































differed in important ways between eventual seroconverters
and control children. The richness and Shannon diversity
of these families was reduced in children who later ser-
oconverted (Zhao et al., 2017). We further identified a subset
of bacteriophage sequences, directly or inversely associated
with seroconversion, that was highly predictive for discrim-
inating between seroconverters and controls (Zhao et al.,
2017).
It is interesting that these differences in bacteriophage
populations before seroconversion were observed despite
the lack of distinguishing bacterial signatures from the same
samples (Kostic et al., 2015). Is it possible that changes in
bacteriophages before seroconversion led to the changes in
bacterial populations and decrease in bacterial diversity seen
by Kostic et al. after seroconversion? Bacteriophages per-
sisting as prophages integrated in bacterial genomes can be
reactivated by various stimuli (Mills et al., 2013). Pertur-
bations to lysogenic-lytic cycles of bacteriophages could
lead to changes in bacteriophage abundance with only a
delayed effect on bacterial populations.
Beyond their influence on bacterial populations, bacte-
riophages may interact with the host directly. Phage Ig-like
protein domains on viral capsids can bind to mucins, thus
concentrating bacteriophages in mucus and providing pro-
tection from bacterial infection (Barr et al., 2013). Bacter-
iophages can gain systemic access from the gut (Duerkop
and Hooper, 2013) and have the potential to exert immu-
nomodulatory effects on various immune cells (Mori et al.,
1996; Eriksson et al., 2009; Gorski et al., 2012). Discerning
whether specific bacteriophages might have more direct
effects on host physiology and disease is made more chal-
lenging by phage hypervariability and rapid shifts that can
lead to change in tropism even from a single nucleotide
change (Liu et al., 2002; Minot et al., 2012). The central role
of bacteriophages in the gut and host physiology, however,
cannot be ignored.
A Long Way from Disease Association
to Causal Relationship
Despite tantalizing hints that CRESS DNA viruses may
play a role in protecting against seroconversion, it remains
to be shown whether their significance can be seen in a
separate and larger cohort, whether the viruses we detected
replicate in humans or reflect an environmental source, and
whether they can show an effect on disease in a T1D model
such as the NOD mouse. Caution is warranted when iden-
tifying specific signatures in sequencing data as potentially
linked to the phenotype in question, and a high burden of
proof and confirmation must be satisfied before a particular
microbiome signature can be said to prevent or accelerate
disease. There is no doubt, however, that a specific virus can
have profound effects on host physiology and disease. How
such a virus fits into the overall landscape of contributing
factors, such as host genetics, host behavior and interactions
with the environment, and the milieu of other microbiome
components, will need to be understood before we contem-
plate introducing commensal viruses to at-risk individuals in
hopes of preventing disease. Our hope is that the continued
advances in technology that have allowed us to glimpse this
possibility will carry us forward to determining whether this
possibility could become reality.
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